Trial intelligence / Profile preview

Nebulized Dexmedetomidine vs Lidocaine for Postoperative Sore Throat in Children

NCT07780760Recruiting

Sponsor
Fayoum University Hospital
Start
Sep 2026
Primary completion
Jan 2027
Countries
1
01

Overview

Randomised, double-blind trial of dexmedetomidine in pharyngitis (2 arms), sponsored by Fayoum University Hospital. Primary endpoint: Incidence of Postoperative Sore Throat. Started Sep 2026; status: recruiting.

02

Drugs

dexmedetomidine
03

Conditions

pharyngitis

Beyond the preview

Go deeper on NCT07780760.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07780760.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call